Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMARCA2 | P51531 | 2/20 | 0.31 |
| ▸ | SMARCA4 | P51532 | 2/20 | 0.31 |
| ▸ | PBRM1 | Q86U86 | 2/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1266571 | 0.61 | CYP19A1 (0.38) | HTR2CHTR2B | |
| SCHEMBL1783661 | 0.60 | BACE1 (0.34) | — | |
| Hydrochloric Acid SCHEMBL30818117 | 0.60 | HTR2C (0.40) | HTR2CHTR2B | |
| SCHEMBL26962672 | 0.59 | MAP3K14 (0.45) | HTR2CHTR2B | |
| SCHEMBL1266237 | 0.59 | MAP3K14 (0.45) | HTR2CHTR2B | |
| SCHEMBL30216657 | 0.59 | MAP3K14 (0.45) | HTR2CHTR2B | |
| SCHEMBL30913028 | 0.58 | MAOB (0.42) | — | |
| SCHEMBL14818084 | 0.58 | PBRM1 (0.41) | SMARCA2SMARCA4PBRM1HTR2CHTR2B | |
| SCHEMBL30913032 | 0.57 | KMT2A (0.37) | — | |
| SCHEMBL20110650 | 0.57 | CA1 (0.38) | SMARCA2SMARCA4PBRM1HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | P2RX5, P2RX4, SLC1A5 | SMARCA2 4206/4885SMARCA4 3697/4885PBRM1 651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.